The DOI matches its Crossref record; 102 of the 102 references it cites were found in a registry or an index.
Expression and Regulation of Xenobiotic-Metabolizing Cytochrome P450 (CYP) Enzymes in Human Lung
Abstract
Pathogenesis of lung diseases, such as lung cancer and chronic obstructive pulmonary disease, is tightly linked to exposure to environmental chemicals, most notably tobacco smoke. Many of the compounds associated with these diseases require an enzymatic activation to exert their deleterious effects on pulmonary cells. These activation reactions are mostly catalyzed by cytochrome P450 (CYP) enzymes. Interindividual differences in the in situ activation and inactivation of chemical toxicants may contribute to the risk of developing lung diseases associated with these compounds. This review summarizes in detail the expression of individual CYP forms in human pulmonary tissue and gives a view on the significance of the pulmonary expression of CYP enzymes. The localization of individual CYP enzymes in various cell types of human lung and the emerging field of regulation of human pulmonary CYP enzymes are discussed. At least CYP1A1 (in smokers), CYP1B1, CYP2B6, CYP2E1, CYP2J2, and CYP3A5 proteins are expressed in human lung, and also other CYP forms are likely to be expressed. Xenobiotic-metabolizing CYP enzymes are mostly expressed in bronchial and bronchiolar epithelium, Clara cells, type II pneumocytes, and alveolar macrophages in human lung, although individual CYP forms have different patterns of localization in pulmonary tissues. Problems in animal to human lung toxicity extrapolation and several specific aspects requiring more detailed assessment are identified.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
P450 superfamily: update on new sequences, gene mapping, accession numbers and nomenclature
Nelson, D. R., Koymans, L., Kamataki, T., Stegeman, J. J., Feyereisen, R., Waxman, D. J., Waterman, M. R., Gotoh, O., Coon, M. J., Estabrook, R. W., et al. (1996) · Pharmacogenetics · doi:10.1097/00008571-199602000-00002 · Cited by 2,945
Tobacco Smoke Carcinogens and Lung Cancer
Hecht, S. S. (1999) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/91.14.1194 · Cited by 1,976
Lehmann, J. M., McKee, D. D., Watson, M. A., Willson, T. M., Moore, J. T., & Kliewer, S. A. (1998) · Journal of Clinical Investigation · doi:10.1172/jci3703 · Cited by 1,576
Biochemistry, Biology, and Carcinogenicity of Tobacco-Specific N-Nitrosamines
Hecht, S. S. (1998) · Chemical Research in Toxicology · doi:10.1021/tx980005y · Cited by 1,071
SXR, a novel steroid and xenobioticsensing nuclear receptor
Blumberg, B., Sabbagh, W., Juguilon, H., Bolado, J., van Meter, C. M., Ong, E. S., & Evans, R. M. (1998) · Genes & Development · doi:10.1101/gad.12.20.3195 · Cited by 919
Cytochrome P450 2C is an EDHF synthase in coronary arteries
Fisslthaler, B., Popp, R., Kiss, L., Potente, M., Harder, D. R., Fleming, I., & Busse, R. (1999) · Nature · doi:10.1038/46816 · Cited by 911
Activation of chemically diverse procarcinogens by human cytochrome P-450 1B1.
Shimada, T., Hayes, C. L., Yamazaki, H., Amin, S., Hecht, S. S., Guengerich, F. P., & Sutter, T. R. (1996) · PubMed · Cited by 895
Cytochrome P-4502E1: its physiological and pathological role
Lieber, C. S. (1997) · Physiological Reviews · doi:10.1152/physrev.1997.77.2.517 · Cited by 889
Identification of a human nuclear receptor defines a new signaling pathway for CYP 3 A induction
Bertilsson, G., Heidrich, J., Svensson, K., Åsman, M., Jendeberg, L., Sydow-Bäckman, M., Ohlsson, R., Postlind, H., Blomquist, P., & Berkenstam, A. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.21.12208 · Cited by 872
Waxman, D. J. (1999) · Archives of Biochemistry and Biophysics · doi:10.1006/abbi.1999.1351 · Cited by 753
Foster, K. A., Oster, C. G., Mayer, M. M., Avery, M. L., & Audus, K. L. (1998) · Experimental Cell Research · doi:10.1006/excr.1998.4172 · Cited by 713
Bartsch, H., Nair, U., Risch, A., Rojas, M., Wikman, H., & Alexandrov, K. (2000) · PubMed · Cited by 627
Capdevila, J. H., Falck, J. R., & Harris, R. C. (2000) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)32049-6 · Cited by 552
Tumor-specific expression of cytochrome P450 CYP1B1.
Murray, G. I., Taylor, M. C., McFadyen, M. C. E., McKay, J., Greenlee, W. F., Burke, M. D., & Melvin, W. T. (1997) · PubMed · Cited by 532
Sutter, T. R., Tang, Y. M., Hayes, C. L., Wo, Y. Y., Jabs, E. W., Li, X., Yin, H., Cody, C. W., & Greenlee, W. F. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)36803-5 · Cited by 508
Reciprocal activation of Xenobiotic response genes by nuclear receptors SXR/PXR and CAR
Xie, W., Barwick, J. L., Simon, C. M., Pierce, A. M., Safe, S., Blumberg, B., Guzelian, P. S., & Evans, R. M. (2000) · Genes & Development · doi:10.1101/gad.846800 · Cited by 508
Baes, M., Gulick, T., Choi, H. S., Martinoli, M. G., Simha, D., & Moore, D. D. (1994) · Molecular and Cellular Biology · doi:10.1128/mcb.14.3.1544 · Cited by 494
Role of Human Cytochromes P450 in the Metabolic Activation of Chemical Carcinogens and Toxins
Gonzalez, F. J., & Gelboin, H. V. (1994) · Drug Metabolism Reviews · doi:10.3109/03602539409029789 · Cited by 493
Wu, S., Moomaw, C. R., Tomer, K. B., Falck, J. R., & Zeldin, D. C. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.7.3460 · Cited by 473
Extrahepatic Metabolism of Drugs in Humans
Krishna, D. R., & Klotz, U. (1994) · Clinical Pharmacokinetics · doi:10.2165/00003088-199426020-00007 · Cited by 437
Studies on the expression and metabolic capabilities of human liver cytochrome P450IIIA5 (HLp3).
Wrighton, S. A., Brian, W. R., Sari, M. A., Iwasaki, M., Guengerich, F. P., Raucy, J. L., Molowa, D. T., & Vandenbranden, M. (1990) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)09441-6 · Cited by 402
Yamazaki, H., Inui, Y., Yun, C.-H., Guengerich, F. P., & Shimada, T. (1992) · Carcinogenesis · doi:10.1093/carcin/13.10.1789 · Cited by 398
Su, T., Bao, Z., Zhang, Q., Smith, T. J., Hong, J., & Ding, X. (2000) · PubMed · Cited by 395
Induction of CYP2C genes in human hepatocytes in primary culture.
Gerbal‐Chaloin, S., Pascussi, J., Pichard‐Garcia, L., Daujat‐Chavanieu, M., Waechter, F., Fabre, J.-M., Carrère, N., & Maurel, P. (2001) · PubMed · Cited by 345
McLemore, T. L., Adelberg, S., Liu, M. C., McMahon, N. A., Yu, S. J., Hubbard, W. C., Czerwinski, M., Wood, T. G., Storeng, R., Lubet, R. A., et al. (1990) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/82.16.1333 · Cited by 340
Regulation, Function, and Tissue-Specific Expression of Cytochrome P450 CYP1B1
Murray, G. I., Melvin, W. T., Greenlee, W. F., & Burke, M. D. (2001) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.41.1.297 · Cited by 336
Steroid hormone hydroxylase specificities of eleven cDNA-expressed human cytochrome P450s
Waxman, D. J., Lapenson, D. P., Aoyama, T., Gelboin, H. V., Gonzalez, F. J., & Korzekwa, K. (1991) · Archives of Biochemistry and Biophysics · doi:10.1016/0003-9861(91)90602-f · Cited by 324
Metabolic Polymorphisms and Susceptibility to Cancer
Vineis, P. (1999) · Cited by 313
Bonvallot, V., Baeza-Squiban, A., Baulig, A., Brulant, S., Boland, S., Muzeau, F., Barouki, R., & Marano, F. (2001) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/ajrcmb.25.4.4515 · Cited by 289
Sex differences in lung CYP1A1 expression and DNA adduct levels among lung cancer patients.
Mollerup, S., Ryberg, D., Hewer, A. J., Phillips, D. H., & Haugen, A. (1999) · PubMed · Cited by 272
Cytochromes P450. Metabolic and Toxicological Aspects
Shuster, L. (1997) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-199708000-00025 · Cited by 271
Human CYP2B6: expression, inducibility and catalytic activities
Gervot, L., Rochat, B., Gautier, J. C., Bohnenstengel, F., Kroemer, H., de Berardinis, V., Martin, H., Beaune, P., & de Waziers, I. (1999) · Pharmacogenetics · doi:10.1097/00008571-199906000-00004 · Cited by 265
Rifkind, A. B., Lee, C., Chang, T. K. H., & Waxman, D. J. (1995) · Archives of Biochemistry and Biophysics · doi:10.1016/0003-9861(95)90023-3 · Cited by 251
Csanády, G. A., Guengerich, F. P., & Bond, J. A. (1992) · Carcinogenesis · doi:10.1093/carcin/13.7.1143 · Cited by 250
Code, E. L., Crespi, C. L., Penman, B. W., Gonzalez, F. J., Chang, T. K. H., & Waxman, D. J. (1997) · PubMed · Cited by 245
Shimada, T., Yamazaki, H., Mimura, M., Wakamiya, N., Ueng, Y., Guengerich, F. P., & Inui, Y. (1996) · PubMed · Cited by 244
Kapitulnik, J., Wislocki, P. G., Levin, W., et al. (1978) · PubMed · Cited by 240
Pascussi, J.-M., Gerbal-Chaloin, S., Pichard-Garcia, L., Daujat, M., Fabre, J.-M., Maurel, P., & Vilarem, M.-J. (2000) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2000.3219 · Cited by 231
Shimada, T., Mv, M., Pruess-Schwartz, D., Marnett, L. J., & Guengerich, F. P. (1989) · PubMed · Cited by 222
Generation and disposal of reactive oxygen metabolites in the lung.
Kinnula, V., Jd, C., & Raivio, K. O. (1995) · PubMed · Cited by 214
cDNA Cloning and Initial Characterization of CYP3A43, a Novel Human Cytochrome P450
Domanski, T. L., Finta, C., Halpert, J. R., & Zaphiropoulos, P. G. (2001) · Molecular Pharmacology · doi:10.1016/s0026-895x(24)12850-7 · Cited by 205
Gene expression in distinct regions of the heart
Thum, T., & Borlak, J. (2000) · The Lancet · doi:10.1016/s0140-6736(00)99016-0 · Cited by 195
Omiecinski, C. J., Redlich, C. A., & Costa, P. (1990) · PubMed · Cited by 187
Cloning and Tissue Distribution of a Novel Human Cytochrome P450 of the CYP3A Subfamily, CYP3A43
Westlind, A., Malmebo, S., Johansson, I., Otter, C., Andersson, T. B., Ingelman-Sundberg, M., & Oscarson, M. (2001) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2001.4505 · Cited by 178
CYP2A6 Gene Deletion Reduces Susceptibility to Lung Cancer
Miyamoto, M., Umetsu, Y., Dosaka‐Akita, H., Sawamura, Y., Yokota, J., Kunitoh, H., Nemoto, N., Sato, K., Ariyoshi, N., & Kamataki, T. (1999) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1999.1089 · Cited by 172
Lumsden, A. B., McLean, A., & Lamb, D. (1984) · Thorax · doi:10.1136/thx.39.11.844 · Cited by 171
Hukkanen, J., Lassila, A., Päivärinta, K., Valanne, S., Sarpo, S., Hakkola, J., Pelkonen, O., & Raunio, H. (2000) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/ajrcmb.22.3.3845 · Cited by 169
Self-citationShou, M., Korzekwa, K. R., Crespi, C. L., Gonzalez, F. J., & Gelboin, H. V. (1994) · Molecular Carcinogenesis · doi:10.1002/mc.2940100307 · Cited by 167
Shijubo, N., Itoh, Y., Yamaguchi, T., Shibuya, Y., Morita, Y., Hirasawa, M., Okutani, R., Kawai, T., & Abe, S. (1997) · European Respiratory Journal · doi:10.1183/09031936.97.10051108 · Cited by 162
Hecht, S. S., Hochalter, J. B., Villalta, P. W., & Murphy, S. E. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.220207697 · Cited by 160
Gerde, P. (2001) · Carcinogenesis · doi:10.1093/carcin/22.5.741 · Cited by 159
CYP2J subfamily P450s in the lung: expression, localization, and potential functional significance.
Zeldin, D. C., Foley, J. F., Ma, J., Boyle, J. E., Pascual, J. M., Moomaw, C. R., Tomer, K. B., Steenbergen, C., & Wu, S. (1996) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)09539-2 · Cited by 156
Expression of CYP2A genes in human liver and extrahepatic tissues
Koskela, S., Hakkola, J., Hukkanen, J., Pelkonen, O., Sorri, M., Saranen, A., Anttila, S. L., Fernández‐Salguero, P. M., Gonzalez, F. J., & Raunio, H. (1999) · Biochemical Pharmacology · doi:10.1016/s0006-2952(99)00015-5 · Cited by 155
Self-citationCantrell, E. T., Warr, G. A., Busbee, D. L., & Martin, R. R. (1973) · Journal of Clinical Investigation · doi:10.1172/jci107371 · Cited by 155
Expression and Localization of CYP3A4 and CYP3A5 in Human Lung
Anttila, S. L., Hukkanen, J., Hakkola, J., Stjernvall, T., Beaune, P. H., Edwards, R. J., Boobis, A. R., Pelkonen, O., & Raunio, H. (1997) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/ajrcmb.16.3.9070608 · Cited by 154
Self-citationBiochemical Characterization of the Human Liver Cytochrome P450 Arachidonic Acid Epoxygenase Pathway
Zeldin, D. C., Moomaw, C. R., Jesse, N., Tomer, K. B., Beetham, J. K., Hammock, B. D., & Wu, S. (1996) · Archives of Biochemistry and Biophysics · doi:10.1006/abbi.1996.0229 · Cited by 150
Identification of a novel dioxin-inducible cytochrome P450
Rivera, S. P., Saarikoski, S. T., & Hankinson, O. (2002) · Molecular Pharmacology · doi:10.1016/s0026-895x(24)12856-8 · Cited by 149
Murray, G. I., Barnes, T., Hf, S., Ewen, S. W. B., Melvin, W., & Burke, M. D. (1988) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.1988.tb03331.x · Cited by 147
Willey, J. C., Coy, E. L., Frampton, M. W., Torres, A., Apostolakos, M. J., Hoehn, G., Schuermann, W. H., Thilly, W. G., Olson, D. E., Hammersley, J. R., et al. (1997) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/ajrcmb.17.1.2783 · Cited by 133
Chemically Reactive Intermediates and Pulmonary Xenobiotic Toxicity
Gram, T. E. (1997) · Pharmacological Reviews · doi:10.1016/s0031-6997(24)01336-x · Cited by 124
Aflatoxin B1Activation in Human Lung
Kelly, J. D., Eaton, D. L., Guengerich, F. P., & Coulombe, R. A. (1997) · Toxicology and Applied Pharmacology · doi:10.1006/taap.1997.8117 · Cited by 120
Phenobarbital-Elicited Activation of Nuclear Receptor CAR in Induction of Cytochrome P450 Genes
Zelko, I. N., & Negishi, M. (2000) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2000.3557 · Cited by 120
Loriot, M., Rebuissou, S., Oscarson, M., Cénée, S., Miyamoto, M., Ariyoshi, N., Kamataki, T., Hémon, D., Beaune, P. H., & Stücker, I. (2001) · Pharmacogenetics · doi:10.1097/00008571-200102000-00005 · Cited by 120
Rosemary components inhibit benzo[a]pyrene-induced genotoxicity in human bronchial cells
Offord, E., Macé, K., Ruffieux, C., Malnoë, A., & Pfeifer, A. M. A. (1995) · Carcinogenesis · doi:10.1093/carcin/16.9.2057 · Cited by 119
Nhamburo, P. T., Gonzalez, F. J., McBride, O. W., Gelboin, H. V., & Kimura, S. (1989) · Biochemistry · doi:10.1021/bi00446a014 · Cited by 119
Scarborough, P. E., Ma, J., Qu, W., & Zeldin, D. C. (1999) · Drug Metabolism Reviews · doi:10.1081/dmr-100101915 · Cited by 110
7-Ethoxycoumarin O-deethylation catalyzed by cytochromes P450 1A2 and 2E1 in human liver microsomes
Yamazaki, H., Inoue, K., Mimura, M., Oda, Y., Guengerich, F. P., & Shimada, T. (1996) · Biochemical Pharmacology · doi:10.1016/0006-2952(95)02178-7 · Cited by 107
Identification and Tissue Distribution of the Novel Human Cytochrome P450 2S1 (CYP2S1)
Rylander‐Rudqvist, T., Neve, E. P. A., Ingelman‐Sundberg, M., & Oscarson, M. (2001) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2001.4390 · Cited by 106
Nhamburo, P. T., Kimura, S., McBride, O. W., Kozak, C. A., Gelboin, H. V., & Gonzalez, F. J. (1990) · Biochemistry · doi:10.1021/bi00475a012 · Cited by 104
Rostami‐Hodjegan, A., Lennard, M. S., Woods, H. F., & Tucker, G. T. (1998) · Pharmacogenetics · doi:10.1097/00008571-199806000-00005 · Cited by 104
Kushida, H., Fujita, K., Suzuki, A., Yamada, M., Endo, T., Nohmi, T., & Kamataki, T. (2000) · Carcinogenesis · doi:10.1093/carcin/21.6.1227 · Cited by 103
A.-M, C. (1989) · Lung Cancer · doi:10.1016/0169-5002(89)90282-1 · Cited by 102
Expression of xenobiotic-metabolizing CYPs in human pulmonary tissue
Raunio, H., Hakkola, J., Hukkanen, J., Lassila, A., Päivärinta, K., Pelkonen, O., Anttila, S. L., Piipari, R., Boobis, A. R., & Edwards, R. J. (1999) · Experimental and Toxicologic Pathology · doi:10.1016/s0940-2993(99)80031-1 · Cited by 101
Self-citationInterindividual difference in expression of human Ah receptor and related P450 genes
Hayashi, S.-I., Watanabe, J. A., Nakachi, K., Eguchi, H., Gotoh, O., & Kawajiri, K. (1994) · Carcinogenesis · doi:10.1093/carcin/15.5.801 · Cited by 98
Quantification of CYP2B7, CYP4B1, and CYPOR messenger RNAs in normal human lung and lung tumors.
Czerwiński, M., McLemore, T. L., Gelboin, H. V., & Gonzalez, F. J. (1994) · PubMed · Cited by 93
Jacobs, E. R., & Zeldin, D. C. (2001) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.2001.280.1.h1 · Cited by 92
Mechanisms of 3-methylindole pneumotoxicity
Yost, G. S. (1989) · Chemical Research in Toxicology · doi:10.1021/tx00011a001 · Cited by 89
Respiratory Tract Uptake of Inhalants and Metabolism of Xenobiotics
Dahl, A. R., & Lewis, J. L. (1993) · The Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pa.33.040193.002123 · Cited by 83
Anttila, S. L., Tuominen, P., Hirvonen, A., Nurminen, M. M., Karjalainen, A., Hankinson, O., & Elovaara, E. (2001) · Pharmacogenetics · doi:10.1097/00008571-200108000-00005 · Cited by 80
Inhaled Naphthalene Causes Dose Dependent Clara Cell Cytotoxicity in Mice but Not in Rats
West, J. A. A., Pakehham, G., Morin, D., Fleschner, C. A., Buckpitt, A. R., & Plopper, C. G. (2001) · Toxicology and Applied Pharmacology · doi:10.1006/taap.2001.9151 · Cited by 78
Kivist, K. T., Griese, E., Fritz, P., Linder, A., Hakkola, J., Raunio, H., Beaune, P. H., & Kroemer, H. (1996) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/bf00168759 · Cited by 74
Self-citationAdlouni, C. E., Pinelli, É., Az�mar, B., Zaoui, D., Beaune, P. H., & Pfohl‐Leszkowicz, A. (2000) · Environmental and Molecular Mutagenesis · Cited by 71
Foth, H. (1995) · Critical Reviews in Toxicology · doi:10.3109/10408449509021612 · Cited by 71
CYP4B1 Is a Possible Risk Factor for Bladder Cancer in Humans
Imaoka, S., Yoneda, Y., Sugimoto, T., Hiroi, T., Yamamoto, K., Nakatani, T., & Funae, Y. (2000) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2000.3740 · Cited by 68
Mastyugin, V., Aversa, E., Bonazzi, A., Vafaes, C., Mieyal, P. A., & Schwartzman, M. L. (1999) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)38312-0 · Cited by 61
Human pulmonary arteries dilate to 20-HETE, an endogenous eicosanoid of lung tissue
Birks, E. K., Bousamra, M., Presberg, K. W., et al. (1997) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.1997.272.5.l823 · Cited by 60
Tissue-specific expression and methylation of the human CYP2E1 gene
Botto, F., Sérée, E., Khyari, S. E., de Sousa, G., Massacrier, A., Placidi, M., Cau, P., Pellet, W., Rahmani, R., & Barra, Y. (1994) · Biochemical Pharmacology · doi:10.1016/0006-2952(94)90145-7 · Cited by 59
Immunohistochemical localization of NADPH-cytochrome P450 reductase in human tissues
Pauline, D. M. H., Stupans, L., Burgess, W. M., Birkett, D., & McManus, M. E. (1989) · Carcinogenesis · doi:10.1093/carcin/10.3.521 · Cited by 59
Zheng, Y.-M., Fisher, M. B., Yokotani, N., Fujii‐Kuriyama, Y., & Rettie, A. E. (1998) · Biochemistry · doi:10.1021/bi981280m · Cited by 58
Human-derived cell lines to study xenobiotic metabolism
Urani, C., Doldi, M., Crippa, S., & Camatini, M. (1998) · Chemosphere · doi:10.1016/s0045-6535(98)00321-x · Cited by 55
Development of an AntiPeptide Antibody That Binds to the C-Terminal Region of Human CYP1B1
Tang, Y., Chen, G.-F., Thompson, P. A., Lin, D., Lang, N. P., & Kadlubar, F. F. (1999) · Drug Metabolism and Disposition · doi:10.1016/s0090-9556(24)15290-7 · Cited by 54
Gerde, P. (1997) · Carcinogenesis · doi:10.1093/carcin/18.9.1825 · Cited by 44
Roberts, E. A., Golas, C. L., & Okey, A. B. (1986) · PubMed · Cited by 43
A Transgenic Mouse Expressing Human CYP4B1 in the Liver
Imaoka, S., Hayashi, K., Hiroi, T., Yabusaki, Y., Kamataki, T., & Funae, Y. (2001) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2001.5055 · Cited by 43
Anttila, S., Lei, X.-D., Elovaara, E., Karjalainen, A., Sun, W., Vainio, H., & Hankinson, O. (2000) · Pharmacogenetics · doi:10.1097/00008571-200011000-00008 · Cited by 41
Gene Expression Profiling of Cultured Human Bronchial Epithelial and Lung Carcinoma Cells
Hellmann, G. M. (2001) · Toxicological Sciences · doi:10.1093/toxsci/61.1.154 · Cited by 40
Forkert, P., & Lee, R. P. (1997) · Toxicology and Applied Pharmacology · doi:10.1006/taap.1997.8233 · Cited by 39
Ngui, J. S., & Bandiera, S. M. (1999) · Toxicology and Applied Pharmacology · doi:10.1006/taap.1999.8787 · Cited by 28
Roth, R. A., & Vinegar, A. (1990) · Pharmacology & Therapeutics · doi:10.1016/0163-7258(90)90078-g · Cited by 25
Analysis of Human Cytochrome P450 Catalytic Activities and Expression.
Gonzalez, F. J., Crespi, C. L., CZERWINSKI, M., & Gelboin, H. V. (1992) · The Tohoku Journal of Experimental Medicine · doi:10.1620/tjem.168.67 · Cited by 21
Spectroscopic quantitation of cytochrome P‐450 in human lung microsomes
Wheeler, C. W., & Guenthner, T. M. (1990) · Journal of Biochemical and Molecular Toxicology · doi:10.1002/jbt.2570050410 · Cited by 19
Clinical and cellular effects of cytochrome P-450 modulators
Tesfaigzi, Y., Kluger, M., & Kozak, W. (2001) · Respiration Physiology · doi:10.1016/s0034-5687(01)00267-5 · Cited by 14
Cited by
Inhibition and induction of human cytochrome P450 enzymes: current status
Pelkonen, O., Turpeinen, M., Hakkola, J., Honkakoski, P., Hukkanen, J., & Raunio, H. (2008) · Archives of Toxicology · doi:10.1007/s00204-008-0332-8 · Cited by 569
Self-citationInhibition and induction of CYP enzymes in humans: an update
Hakkola, J., Hukkanen, J., Turpeinen, M., & Pelkonen, O. (2020) · Archives of Toxicology · doi:10.1007/s00204-020-02936-7 · Cited by 418
Self-citationPolymorphisms of DNA repair genes and risk of non-small cell lung cancer
Zienolddiny, S., Campa, D., Lind, H., Ryberg, D., Skaug, V., Stangeland, L., Phillips, D. H., Canzian, F., & Haugen, A. (2006) · Carcinogenesis · doi:10.1093/carcin/bgi232 · Cited by 405
Bièche, I., Narjoz, C., Asselah, T., Vacher, S., Marcellin, P., Lidereau, R., Beaune, P., & de Waziers, I. (2007) · Pharmacogenetics and Genomics · doi:10.1097/fpc.0b013e32810f2e58 · Cited by 341
Inhaled Therapy in Respiratory Disease: The Complex Interplay of Pulmonary Kinetic Processes
Borghardt, J. M., Kloft, C., & Sharma, A. (2018) · Canadian Respiratory Journal · doi:10.1155/2018/2732017 · Cited by 304
Metadata
- Authors
- Hukkanen, J., Pelkonen, O., Hakkola, J., & Raunio, H.
- Venue
- Critical Reviews in Toxicology
- Publisher
- Informa UK Limited
- Published
- 2002-01
- Volume
- 32
- Issue
- 5
- Pages
- 391-411
- ISSN
- 0045-6446 (ISSN-L)
- 1040-8444
- 1547-6898
- OpenAlex
- W2017320011
- Cited by
- 318
- References
- 102
- FWCI
- 7.96
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.